Skip to main content

Schneeberger Daniel

In the past year, 21 open-market purchase filings worth $13.2M and no sales.

Current role at each company

  • INMInMed Pharmaceuticals Inc.10% Owneras of Nov 9, 2026
  • NXTCNextCure, Inc.10% Owneras of Nov 9, 2026
  • TENXTenax Therapeutics, Inc.10% Owneras of Oct 21, 2026
  • RLYBRallybio Corp10% Owneras of May 20, 2026
  • KROSKeros Therapeutics, Inc.10% Owneras of Oct 15, 2025

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$13.2M
21 filings
Sold
–
0 filings
Net
+$13.2M
Bought minus sold
Companies
4
With open-market trades

Trades

Every Form 4 that lists Schneeberger Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

INM InMed Pharmaceuticals Inc.

10% Owner9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 9, 2026 (view filing)8:18 PM ETNov 54 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+2.64K$13.10+$34.6K+2.8%98.3K after
Oct 27, 2026 (view filing)2:13 PM ETOct 234 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+4$1.32+$5.280.0%956.6K after
Oct 20, 2026 (view filing)5:31 PM ETOct 16-194 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+1.09K$1.32+$1.43K+0.1%956.6K after2 lots
Oct 15, 2026 (view filing)4:39 PM ETOct 13-152 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+9.57K$1.33+$12.7K+1.0%955.5K after3 lots
Oct 8, 2026 (view filing)6:27 PM ETOct 6-82 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+10.9K$1.33+$14.5K+1.2%945.9K after3 lots
Oct 5, 2026 (view filing)5:11 PM ETOct 1-54 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+42.9K$1.33+$57.1K+4.8%935.0K after3 lots
Sep 16, 2026 (view filing)6:58 PM ETSep 14-162 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+91.1K$1.30+$118.1K+11.4%892.1K after3 lots
Jul 17, 2026 (view filing)7:29 PM ETJul 152 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+1.00K$1.56+$1.55K+0.1%801.0K after
May 21, 2026 (view filing)5:08 PM ETMay 192 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+468.6K$1.54+$721.5K+141.4%800.0K after3 lots

NXTC NextCure, Inc.

10% Owner4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 9, 2026 (view filing)4:19 PM ETNov 5-64 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+4.69K$5.10+$23.9K+0.6%738.0K after2 lots
Oct 27, 2026 (view filing)7:36 PM ETOct 23-274 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+10.9K$4.95+$53.7K+1.5%733.3K after3 lots
Aug 3, 2026 (view filing)5:53 PM ETJul 30-314 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+329.2K$4.93+$1.62M+83.7%722.4K after9 lots
Jul 29, 2026 (view filing)6:18 PM ETJul 27-292 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+17.6K$4.98+$87.7K+4.7%393.3K after4 lots

TENX Tenax Therapeutics, Inc.

10% Owner4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 21, 2026 (view filing)4:49 PM ETOct 19-212 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+922.8K$1.59+$1.46M+14.1%7.45M after3 lots
Sep 8, 2026 (view filing)5:16 PM ETSep 35 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+900.0K$1.78+$1.60M+16.0%6.52M after
Sep 2, 2026 (view filing)5:52 PM ETAug 31-Sep 22 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+770.3K$1.79+$1.38M+15.9%5.62M after3 lots
Aug 24, 2026 (view filing)6:12 PM ETAug 20-244 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+1.03M$1.77+$1.81M+26.8%4.85M after3 lots

RLYB Rallybio Corp

10% Owner4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 20, 2026 (view filing)8:45 PM ETMay 18-192 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+16.2K$13.98+$226.6K+1.8%926.4K after3 lots
May 15, 2026 (view filing)8:49 PM ETMay 13-152 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+79.6K$13.99+$1.11M+9.6%910.1K after4 lots
May 13, 2026 (view filing)9:22 PM ETMay 11-122 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+50.8K$14.00+$711.1K+6.5%830.6K after4 lots
May 6, 2026 (view filing)9:32 PM ETMay 4-52 daysSchneeberger Daniel and 1 other10% OwnerPPurchase+155.9K$13.97+$2.18M+25.0%779.8K after3 lots

KROS Keros Therapeutics, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 15, 2025 (view filing)1:24 PM ETOct 15Same dayADAR1 Partners, LP and 3 others10% OwnerSSale−5.39M$17.75−$95.7M−100.0%0 after3 lots
Apr 11, 2025 (view filing)9:57 PM ETApr 92 daysADAR1 Partners, LP and 3 others10% OwnerPPurchase+934.3K$10.13+$9.46M+27.0%4.39M after5 lots